Versuchen GOLD - Frei
America is Hooked on Antidepressants
Newsweek US
|September 30, 2022
Popular medications work no better than placebo for millions of Americans and can come with severe withdrawal symptoms. Why do doctors prescribe them to 43 million Americans?
Five years ago Mark Horowitz seemed an unlikely skeptic of psycho-pharmaceuticals. He had been taking the popular antidepressant Lexapro virtually every day for 15 years. He was so fascinated by the drugs that he spent three years hunched over a dish of human brain cells in a laboratory at King's College London, measuring the effect of human stress hormones and drugs like Prozac and Zoloft.
Then, when he tried to wean himself off the medication, he suffered panic attacks, sleep disruptions and a depression so debilitating that he had to move back to his parents' house in Australia-symptoms that he says were far worse than anything he experienced prior to going on the drugs. He went online and found thousands of others in a similar pickle. They had been unable to kick one of the psychiatric drugs known as Selective Serotonin Reuptake Inhibitors, or SSRIs, which include Lexapro, Zoloft and Prozac, among others. Since withdrawal symptoms were thought to be mild and temporary, many of them, like him, had been told by doctors that they were experiencing a relapse of their depression. The experience galvanized Horowitz to dig deeper into the claims that pharmaceutical companies, and the scientists they fund, have been making about these popular antidepressants.
Hailed as a revolution for the treatment of depression when they first came out in the 1980s, SSRIs have become a mainstay of mental health treatment. Family doctors with little psychiatric training now prescribe them for adults and children alike. In 2019, one in eight Americans-43 million in all-were taking an SSRI, and those numbers have likely risen among a public ridden with COVID-induced anxiety. During the pandemic, doctors phoned in so many new prescriptions for Zoloft, the FDA warned of a drug shortage.
Diese Geschichte stammt aus der September 30, 2022-Ausgabe von Newsweek US.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Newsweek US
Newsweek US
TURN THESE PAGES
The best books Newsweek staffers read last year
8 mins
January 2, 2026
Newsweek US
CHERYL HINES
The actor discusses her new memoir Unscripted, her Hollywood roots and life with husband Robert F. Kennedy Jr. inside the Trump administration
2 mins
January 2, 2026
Newsweek US
THE MIDDLE CLASS FLORIDA DREAM IS OVER
Higher housing costs are pushing a life in the Sunshine State out of reach for many Americans
11 mins
January 2, 2026
Newsweek US
MIND GAMES
Mentalist Oz Pearlman on using storytelling to read his audience and the secret to sticking to New Year's resolutions
6 mins
January 2, 2026
Newsweek US
DACRE MONTGOMERY
DACRE MONTGOMERY HAS HAD A LOT OF PINCH-ME MOMENTS IN THE PAST few years.
1 mins
January 2, 2026
Newsweek US
GEN Z IS LIT
Images of celebrities smoking have become popular on social media among young people, despite the generation's clean-living image
4 mins
January 2, 2026
Newsweek US
AMERICA'S BEST REGIONAL BANKS & CREDIT UNIONS 2026
These financial institutions are ones you can trust for your business and personal banking relationshipswithout the corporate feel
4 mins
January 2, 2026
Newsweek US
Complete Control
Kate Winslet has been a screen icon for three decades. Now she's stepped behind the camera to direct her first feature film
8 mins
January 2, 2026
Newsweek US
From the Arctic to the Sahara, Extremes Put New Vehicles to the Test
BATTLE TESTED Mercedes-Benz GLB undergoes extreme conditions testing in Germany.
1 mins
December 26, 2025
Newsweek US
'IF HE GETS RID OF MADURO, WE'LL FORGIVE HIM'
Venezuelan exiles in a Miami suburb are backing Trump's efforts to remove the leader from power
4 mins
December 26, 2025
Translate
Change font size
